-
公开(公告)号：US20210054057A1
公开(公告)日：2021-02-25
申请号：US16895471
申请日：2020-06-08
申请人： H. Lundbeck A/S
发明人： Pekka KALLUNKI , Karina FOG , Louise Buur VESTERAGER , Ann-Louise BERGSTRÔM , Florence SOTTY , David SATIJN , Edward VAN DEN BRINK , Paul PARREN , Rik RADEMAKER , Tom VINK , Ibrahim John MALIK , Liliana Christina Pereira MONTEZINHO
摘要： The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.
-
公开(公告)号：US20210061892A1
公开(公告)日：2021-03-04
申请号：US17088307
申请日：2020-11-03
申请人： H. Lundbeck A/S
发明人： Pekka KALLUNKI , Karina FOG , Louise Buur VESTERAGER , Ann-Louise BERGSTRÔM , Florence SOTTY , David SATIJN , Edward VAN DEN BRINK , Paul PARREN , Rik RADEMAKER , Tom VINK , Ibrahim John MALIK , Liliana Christina Pereira MONTEZINHO
摘要： The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.
-
公开(公告)号：US20230312693A1
公开(公告)日：2023-10-05
申请号：US17992403
申请日：2022-11-22
申请人： H. Lundbeck A/S
发明人： Pekka KALLUNKI , Karina FOG , Louise Buur VESTERAGER , Ann-Louise BERGSTRÔM , Florence SOTTY , David SATIJN , Edward VAN DEN BRINK , Paul PARREN , Rik RADEMAKER , Tom VINK , Ibrahim John MALIK , Liliana Christina Pereira MONTEZINHO , Jeffrey B STAVENHAGEN
CPC分类号： C07K16/18 , A61K51/00 , A61K39/3955 , A61K2039/505 , A61P25/28 , G01N33/6896 , A61P25/16
摘要： The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.
-
公开(公告)号：US20190382473A1
公开(公告)日：2019-12-19
申请号：US16443225
申请日：2019-06-17
申请人： H. Lundbeck A/S
发明人： Pekka KALLUNKI , Karina FOG , Louise Buur VESTERAGER , Ann-Louise BERGSTRÔM , Florence SOTTY , David SATIJN , Edward VAN DEN BRINK , Paul PARREN , Rik RADEMAKER , Tom VINK , Ibrahim John MALIK , Liliana Christina Pereira MONTEZINHO
IPC分类号： C07K16/18 , G01N33/68 , A61K39/395 , A61K51/00
摘要： The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.
-
公开(公告)号：US20210147522A1
公开(公告)日：2021-05-20
申请号：US17004447
申请日：2020-08-27
申请人： H. Lundbeck A/S
发明人： Pekka KALLUNKI , Karina FOG , Louise Buur VESTERAGER , Ann-Louise BERGSTRÔM , Florence SOTTY , David SATIJN , Edward VAN DEN BRINK , Paul PARREN , Rik RADEMAKER , Tom VINK , Ibrahim John MALIK , Liliana Christina Pereira MONTEZINHO
摘要： The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.
-
-
-
-
搜索结果
5 条记录 (耗时 0.021 秒)
